Craig C. Hopkinson

EVP R&D, Chief Medical Officer

Craig C. Hopkinson (EVP R&D, Chief Medical Officer) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Alkermes plc (ALKS). The largest single filing was $437K of ALKS (9,000 sh × $48.58, as filed), executed Aug 3.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 14 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$3.9M

shares × price, as filed

Last traded

Sep 1

Filed Sep 1

Median ADV $102.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $23.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 14 filings

Sector per market data · by filing · past 12 months

Most traded names

ALKS

Alkermes plc ALKS · 0 buys · 21 sells 21 filings

Recent filings

ALKSSALE Alkermes plc View filing → $423K
9,000 sh × $46.99
Exec Sep 1
Filed Sep 1 · 7:08 PM ET ALKSSALE Alkermes plc View filing → $437K
9,000 sh × $48.58
Exec Aug 3
Filed Aug 3 · 7:12 PM ET ALKSSALE Alkermes plc View filing → $427K
8,300 sh × $51.46
Exec Jul 1
Filed Jul 1 · 6:29 PM ET ALKSSALE Alkermes plc View filing → $375K
9,000 sh × $41.67
Exec Jun 1
Filed Jun 1 · 5:30 PM ET ALKSSALE Alkermes plc View filing → $301K
9,000 sh × $33.40
Exec May 1
Filed May 1 · 5:30 PM ET ALKSSALE Alkermes plc View filing → $320K
9,000 sh × $35.51
Exec Apr 1
Filed Apr 1 · 5:30 PM ET ALKSSALE Alkermes plc View filing → $267K
9,000 sh × $29.72
Exec Mar 2
Filed Mar 4 · 5:30 PM ET ALKSSALE Alkermes plc View filing → $305K
9,000 sh across 2 lots
Exec Feb 2
Filed Feb 2 · 5:30 PM ET More filings →